Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1832334 | 0.81 | TET2 (0.34) | — | |
| SCHEMBL2048457 | 0.81 | TET2 (0.34) | — | |
| SCHEMBL7080197 | 0.78 | TSHR (0.46) | TSHRSMN1; SMN2 | |
| SCHEMBL1900176 | 0.77 | FFAR4 (0.45) | TSHRSMN1; SMN2 | |
| SCHEMBL1896642 | 0.77 | FFAR4 (0.45) | TSHRSMN1; SMN2 | |
| SCHEMBL1905242 | 0.77 | FFAR4 (0.45) | TSHRSMN1; SMN2 | |
| SCHEMBL1897351 | 0.77 | FFAR4 (0.45) | TSHRSMN1; SMN2 | |
| SCHEMBL1897509 | 0.76 | FFAR4 (0.44) | TSHRSMN1; SMN2 | |
| SCHEMBL2045268 | 0.73 | TSHR (0.31) | TSHRSMN1; SMN2 | |
| SCHEMBL27627 | 0.73 | BLM (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2321254-B1 | FUNCTIONALIZED (METH)ACRYLATE MONOMER, POLYMER, COATING AGENT, AND PRODUCTION AND CROSS-LINKING METHOD | EVONIK ROEHM GMBH (DE) | 2014-07-30 | — | — | EP | disclosed |
| US-20110144267-A1 | FUNCTIONALIZED (METH)ACRYLATE MONOMER, POLYMER, COATING AGENT, AND PRODUCTION AND CROSS-LINKING METHOD | EVONIK ROEHM GMBH (DE) | 2011-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110144267-A1 | FUNCTIONALIZED (METH)ACRYLATE MONOMER, POLYMER, COATING AGENT, AND PRODUCTION AND CROSS-LINKING METHOD | DNMT1, TET1, MGMT | TSHR 2023/4885SMN1; SMN2 1750/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.